The antenatal screening service carried out by the Wolfson Institute is being discontinued in June 2022 and all samples for Down’s Risk Screening (first or second trimester) will be referred to the specialist service at Addenbrooke’s Hospital from 23rd May 2022.

TDL test code STDX is now being processed as an in-house assay. There is no change to methodology (NAAT) or sample requirement. TAT remains unchanged.

Following a review of the contracts with referral laboratories, we have identified two laboratories that whilst being ‘GDPR Compliant’, do not follow the typical data model.

The ALEX² test allows for IgE multiplexing of c300 allergens (extracts and molecular allergens) from
a small volume serum sample.

Culture for Mycoplasma, Ureaplasma and Trichomonas vaginalis has been replaced by more sensitive and specific targeted PCR testing.